CD25 and TNF receptor II reflect early primary response to infliximab therapy in patients with ulcerative colitis. - Magnusson MK; Dahlén R; Strid H; Isaksson S; Simrén M; Lasson A; Bajor A; Ung KA; Ohman L (United European gastroenterology journal, 2013)